FF301 致：香港交易及結算所有限公司 公司名稱: 現代健康科技控股有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00919 | 說明 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 10,000,000,000 | HKD | | 0.1 HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | 0 | | HKD | | 0 | | 本月底結存 | | 10,000,000,000 | HKD | | 0.1 HKD | | 1,000,000,000 | 本月底法定/註冊股本總額： HKD 1,000,000,000 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 現代健康科技控股有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2026年1月7日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00919 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.1 HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.1 HKD | | 1,000,00 ...

(Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） （Stock Code 股份代號：919） NOTIFICATION LETTER 通知信函 23 December 2025 Dear Registered Shareholder, Modern Healthcare Technology Holdings Limited (the "Company") – Notice of publication of 2025 Interim Report ("Current Corporate Communication") on the Company's website The English and Chinese versions of the Company's Current Corporate Communications are now available on the Company's website at https://www.modernhealthcaretech.com and th ...

MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED 現代健康科技控股有限公司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） （Stock Code 股份代號：919） As a Non-Registered Holder, if you wish to receive Corporate Communications of the Company in electronic form, you should liaise with your bank(s), broker(s), custodian(s), nominee(s) or HKSCC Nominees Limited through which your shares in the Company are held (collectively, the "Intermediaries") and provide your email address to your Intermediaries. Pl ...

Revenue Performance - The group's revenue for the six months ended September 30, 2025, decreased by 0.7% to HKD 222,674,000 compared to HKD 224,248,000 in the same period last year[11]. - Revenue from beauty and facial care services decreased by 5.2% to HKD 149,697,000, while body services revenue slightly decreased by 0.3% to HKD 43,469,000[12][13]. - Revenue from spa and massage services increased by 28.6% to HKD 9,502,000, and product sales revenue rose by 30.0% to HKD 20,006,000[13]. - Revenue from external customers for the six months ended September 30, 2025, was HKD 222,674,000, a slight decrease of 0.3% compared to HKD 224,248,000 for the same period in 2024[70]. - Revenue from beauty and wellness services was HKD 202,668,000 for the six months ended September 30, 2025, compared to HKD 208,862,000 for the same period in 2024[75]. - Revenue from the sale of skincare and wellness products increased to HKD 20,006,000 for the six months ended September 30, 2025, up from HKD 15,386,000 in the same period of 2024[75]. - The geographical breakdown shows that revenue from Hong Kong was HKD 198,477,000 for the six months ended September 30, 2025, compared to HKD 199,375,000 in 2024[74]. Financial Performance - The net profit for the six months ending September 30, 2025, is approximately HKD 6,946,000, compared to a net loss of HKD 16,125,000 in the same period last year[18]. - Earnings per share for the review period is HKD 0.72, while the loss per share in the previous year was HKD 1.80[18]. - Operating profit for the period was HKD 8,594,000, compared to an operating loss of HKD 10,068,000 in the previous year, indicating a significant turnaround[57]. - Total comprehensive income for the period was HKD 8,547,000, compared to a total comprehensive loss of HKD 14,060,000 in the same period last year[58]. - The company reported a net cash outflow from investing activities of HKD 8,252,000 for the six months ended September 30, 2025, compared to HKD 4,722,000 in the previous year, reflecting a 74% increase in cash used for investments[62]. - The company incurred a loss of HKD 16,302,000 during the six months ended September 30, 2024, which was a significant factor in the overall comprehensive income decline[61]. Cost Management - Employee benefits expenses decreased by approximately 11.3% to HKD 131,325,000, with total employees reduced to 791 from 850, a decrease of 6.9%[14]. - Bank charges decreased by 4.6% to HKD 11,947,000, while advertising expenses decreased to HKD 839,000 from HKD 1,031,000 in the previous year[16]. - The company aims to significantly reduce rental costs, which are one of its main operating expenses, thereby directly enhancing profitability and future financial stability[30]. - The company reported a significant reduction in employee benefits expenses from HKD 148,071,000 in the previous year to HKD 131,325,000[57]. Corporate Governance - The company has adopted corporate governance principles to enhance shareholder value and ensure transparency and accountability[43]. - The company has established various committees, including the Remuneration Committee, Nomination Committee, and Audit Committee, to strengthen governance[47]. - The Remuneration Committee is responsible for reviewing and determining the remuneration of directors and senior management based on established policies[49]. - The company has complied with the standards of the Listing Rules regarding directors' securities trading during the review period[46]. Strategic Initiatives - The group aims to expand its product sales business through the promotion of various skincare brands and its own brands[8]. - A strategic plan is in place to integrate artificial intelligence into operations, automating daily administrative and inventory management tasks to improve accuracy and free up human resources for value-added activities[31]. - The introduction of AI tools, such as intelligent chatbots and personalized recommendation systems, is expected to enhance customer experience by providing instant support and tailored product suggestions[31]. - The company is focused on creating a robust framework for sustainable growth and increased competitiveness in the active beauty service market by reducing fixed costs and improving operational efficiency through AI[32]. Shareholder Information - The founder of the trust holds 677,247,942 shares, representing 74.88% of the company's issued share capital, indicating strong insider ownership[35]. - As of September 30, 2025, the total number of issued shares of the company is 904,483,942[37]. - The company did not declare or pay any dividends for the six-month period ending September 30, 2025[91]. Asset and Liability Management - Total equity as of September 30, 2025, is HKD 199,746,000, with cash and bank balances amounting to HKD 248,509,000[20]. - Non-current assets decreased from HKD 198,393,000 as of March 31, 2025, to HKD 190,027,000 as of September 30, 2025[59]. - Current liabilities decreased from HKD 352,290,000 as of March 31, 2025, to HKD 328,130,000 as of September 30, 2025, indicating improved liquidity[59]. - Total liabilities as of September 30, 2025, were HKD 362,051,000, down from HKD 373,260,000 as of March 31, 2025[72]. Operational Insights - The company operates 29 beauty and health service centers in Hong Kong, with a total floor area of approximately 153,970 square feet, a decrease of 1.4% from 156,090 square feet as of September 30, 2024[7][15]. - In Singapore, the group operates 8 beauty and health service centers, maintaining the same number as last year, with revenue recorded at HKD 23,524,000[10]. - The company has a proactive strategy to renegotiate existing leases and secure better terms for new store locations, enhancing its bargaining power in the current market[30]. - The company emphasizes environmental protection by implementing policies to minimize the use of air conditioning and reduce water consumption in service centers[30].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不會就因本公佈全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED （現 代 健 康 科 技 控 股 有 限 公 司） （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） （股 份 代 號：919） 開曼群島股份登記處及過戶辦事處 以及開曼群島註冊辦事處的地址變更 開曼群島股份登記處及過戶辦事處以及開曼群島註冊辦事處的地址變更 現代健康科技控股有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此宣佈，自 2025年12月9日起，本公司的開曼群島股份登記處及過戶辦事處以及開曼群島註 冊辦事處的地址已更改為： 開曼群島股份登記處及過戶辦事處： Vistra (Cayman) Limited P.O. Box 31119 Grand Pavilion Hibiscus Way, 802 West Bay Road Grand Cayman, KY1 – 1205 Ca ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 現代健康科技控股有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年12月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00919 | 說明 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 10,000,000,000 | HKD | | 0.1 HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | 0 | | HKD | | 0 | | 本月底結存 | | 10,000,000,000 | HKD | | 0.1 HKD | | 1,000,000,000 | 第 1 頁 共 1 ...

Group 1 - The core viewpoint of the article is that Modern Health Technology (00919) reported a slight decrease in revenue for the six months ending September 30, 2025, while achieving a profit for equity shareholders compared to a loss in the previous year [1] Group 2 - The company achieved revenue of HKD 223 million, a year-on-year decrease of 0.7% [1] - The profit attributable to equity shareholders was HKD 6.544 million, a significant improvement from a loss of HKD 16.302 million in the same period last year [1] - Basic earnings per share were HKD 0.072 [1] Group 3 - Revenue from beauty and facial care services decreased by 5.2% compared to the same period last year [1] - Revenue from body shaping services saw a slight decrease of approximately 0.3% compared to 2024 [1] - Revenue from spa bathing and massage services increased by 28.6% during the review period [1] - Product revenue increased by 30.0% compared to the same period last year [1]

Core Viewpoint - Modern Health Technology (00919) reported a revenue of HKD 223 million for the six months ending September 30, 2025, representing a year-on-year decrease of 0.7% [1] Financial Performance - The company's profit attributable to equity shareholders was HKD 6.544 million, a significant improvement from a loss of HKD 16.302 million in the same period last year [1] - Basic earnings per share were HKD 0.072 [1] Revenue Breakdown - The group's revenue primarily comes from beauty, facial care, and body slimming services, with beauty and facial care service revenue decreasing by 5.2% compared to the same period last year [1] - Revenue from body slimming services saw a slight decrease of approximately 0.3% compared to 2024 [1] - Revenue from spa bathing and massage services increased by 28.6% during the review period [1] - Product revenue increased by 30.0% compared to the same period last year [1]

Group 1 - The core viewpoint of the article is that Modern Health Technology (00919.HK) reported a slight decrease in revenue but achieved a net profit compared to a loss in the previous year [1] - For the six months ending September 30, 2025, the group's revenue decreased by 0.7% to HKD 223 million [1] - The net profit for the period was approximately HKD 6.946 million, contrasting with a net loss of HKD 16.125 million in the same period last year [1] Group 2 - The earnings per share for the period were HKD 0.72, while the previous year's earnings per share reflected a loss of HKD 1.80 [1] - The company did not declare or pay any dividends for the six months ending September 30, 2025, and 2024 [1] - The company aims to expand its business at the appropriate time to achieve long-term value and maximize returns for shareholders [1]